Stockreport

Progenity Announces Pricing of $40 Million Public Offering of Common Stock and Warrants

Biora Therapeutics, Inc.  (PROG) 
PDF SAN DIEGO, Aug. 19, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (“Progenity”) (Nasdaq: PROG), an innovative biotechnology company, today announced the pricing of its prev [Read more]